I. Kuss, Carsten Schaefer, T. Godfrey, R. Ferris, Jeffrey Harris, W. Gooding, T. Whiteside (2005)
Recent thymic emigrants and subsets of naive and memory T cells in the circulation of patients with head and neck cancer.Clinical immunology, 116 1
M. Bérard, K. Brandt, Silvia Paus, D. Tough (2003)
IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells1The Journal of Immunology, 170
C. Bergmann, L. Strauss, R. Zeidler, S. Lang, T. Whiteside (2007)
Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.Cancer research, 67 18
D. Altieri (2005)
T cell expansion: the survivin interface between cell proliferation and cell death.Immunity, 22 5
S. Ferrone, T. Whiteside (2008)
Histocompatibility Antigens, Tumor Microenvironment and Escape Mechanisms Utilized by Tumor Cells
T. Boon, P. Coulie, B. Eynde (1997)
Tumor antigens recognized by T cells.Immunology today, 18 6
M. Battaglia, A. Stabilini, B. Migliavacca, J. Horejs-Hoeck, T. Kaupper, M. Roncarolo (2006)
Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients1The Journal of Immunology, 177
S. Rosenberg (2001)
Progress in human tumour immunology and immunotherapyNature, 411
L. Gattinoni, S. Finkelstein, C. Klebanoff, P. Antony, D. Palmer, P. Spiess, L. Hwang, Zhiya Yu, Claudia Wrzesinski, D. Heimann, C. Surh, S. Rosenberg, N. Restifo (2005)
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cellsThe Journal of Experimental Medicine, 202
A. Albers, R. Ferris, Grace Kim, K. Chikamatsu, A. Deleo, T. Whiteside (2005)
Immune responses to p53 in patients with cancer:enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sitesCancer Immunology, Immunotherapy, 54
F. Ichihara, K. Kono, Akihiro Takahashi, Hiromichi Kawaida, H. Sugai, H. Fujii (2003)
Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.Clinical cancer research : an official journal of the American Association for Cancer Research, 9 12
A. Albers, C. Visús, T. Tsukishiro, R. Ferris, W. Gooding, T. Whiteside, A. Leo (2006)
Alterations in the T-Cell Receptor Variable β Gene–Restricted Profile of CD8+ T Lymphocytes in the Peripheral Circulation of Patients with Squamous Cell Carcinoma of the Head and NeckClinical Cancer Research, 12
Jeong-Whun Kim, R. Ferris, T. Whiteside (2005)
Chemokine C Receptor 7 Expression and Protection of Circulating CD8+ T Lymphocytes from ApoptosisClinical Cancer Research, 11
U. Liyanage, T. Moore, H. Joo, Yoshiyuki Tanaka, V. Herrmann, G. Doherty, J. Drebin, S. Strasberg, T. Eberlein, P. Goedegebuure, D. Linehan (2002)
Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma1The Journal of Immunology, 169
E. Carlo, D. Totero, T. Piazza, M. Fabbi, S. Ferrini (2007)
Role of IL-21 in immune-regulation and tumor immunotherapyCancer Immunology, Immunotherapy, 56
L. Old, Yao-Tseng Chen (1998)
New Paths in Human Cancer SerologyThe Journal of Experimental Medicine, 187
R. Kim, M. Emi, K. Tanabe, K. Arihiro (2007)
Potential functional role of plasmacytoid dendritic cells in cancer immunityImmunology, 121
K. Peggs, S. Quezada, A. Korman, J. Allison (2006)
Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.Current opinion in immunology, 18 2
S. Ye, Hong Yang, Ke Li, D. Dong, Xin-mei Lin, S. Yie (2007)
Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancerModern Pathology, 20
M. Beyer, M. Kochanek, Kamruz Darabi, A. Popov, M. Jensen, E. Endl, P. Knolle, Roman Thomas, M. Bergwelt-Baildon, S. Debey, M. Hallek, J. Schultze (2005)
Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine.Blood, 106 6
E. Shevach (2002)
CD4+CD25+ suppressor T cells: more questions than answersNature Reviews Immunology, 2
C. June (2007)
Adoptive T cell therapy for cancer in the clinic.The Journal of clinical investigation, 117 6
G. Parmiani, A. Filippo, L. Novellino, C. Castelli (2007)
Unique Human Tumor Antigens: Immunobiology and Use in Clinical Trials1The Journal of Immunology, 178
L. Rivoltini, P. Canese, V. Huber, M. Iero, L. Pilla, R. Valenti, S. Fais, F. Lozupone, C. Casati, C. Castelli, G. Parmiani (2005)
Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?Expert Opinion on Biological Therapy, 5
R. Kalluri, M. Zeisberg (2006)
Fibroblasts in cancerNature Reviews Cancer, 6
G. Parmiani, C. Castelli, L. Rivoltini (2005)
Chemokine Receptor 7, A New Player in Regulating Apoptosis of CD8+ T Cells in Cancer PatientsClinical Cancer Research, 11
Helen Wang, Dean Lee, Guangyong Peng, Zhong Guo, Yanchun Li, Y. Kiniwa, E. Shevach, Rong-Fu Wang (2004)
Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy.Immunity, 20 1
C. Bergmann, L. Strauss, R. Zeidler, S. Lang, T. Whiteside (2007)
Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironmentCancer Immunology, Immunotherapy, 56
B. Hemmings (1997)
Akt Signaling--Linking Membrane Events to Life and Death DecisionsScience, 275
V. Pistoia, F. Morandi, Xinhui Wang, S. Ferrone (2007)
Soluble HLA-G: Are they clinically relevant?Seminars in cancer biology, 17 6
C. Wimmer, M. Rentsch, Alexander Crispin, W. Illner, H. Arbogast, C. Graeb, K. Jauch, Markus Guba (2007)
The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich.Kidney international, 71 12
S. Kaech, Joyce Tan, E. Wherry, B. Konieczny, C. Surh, R. Ahmed (2003)
Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cellsNature Immunology, 4
M. Burnet (1964)
IMMUNOLOGICAL FACTORS IN THE PROCESS OF CARCINOGENESIS.British medical bulletin, 20
B. Barnett, Ilona Kryczek, P. Cheng, W. Zou, T. Curiel (2005)
Regulatory T Cells in Ovarian Cancer: Biology and Therapeutic PotentialAmerican Journal of Reproductive Immunology, 54
Edward Woo, Christina Chu, Theresa Goletz, Katia Schlienger, Heidi Yeh, G. Coukos, Stephen Rubin, Larry Kaiser, Carl June (2001)
Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.Cancer research, 61 12
J. Dannull, Z. Su, D. Rizzieri, Benjamin Yang, Doris Coleman, Donna Yancey, A. Zhang, P. Dahm, N. Chao, E. Gilboa, J. Vieweg (2005)
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells.The Journal of clinical investigation, 115 12
H. Nishikawa, Takuma Kato, I. Tawara, T. Takemitsu, Kanako Saito, Linan Wang, Y. Ikarashi, H. Wakasugi, T. Nakayama, M. Taniguchi, K. Kuribayashi, L. Old, H. Shiku (2005)
Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts.Proceedings of the National Academy of Sciences of the United States of America, 102 26
I. Kuss, A. Donnenberg, W. Gooding, T. Whiteside (2003)
Effector CD8+CD45RO−CD27−T cells have signalling defects in patients with squamous cell carcinoma of the head and neckBritish Journal of Cancer, 88
Q. Deveraux, John Reed (1999)
IAP family proteins--suppressors of apoptosis.Genes & development, 13 3
G. Schuler, B. Schuler-Thurner, R. Steinman (2003)
The use of dendritic cells in cancer immunotherapy.Current opinion in immunology, 15 2
I. Kuss, T. Saito, J. Johnson, T. Whiteside (1999)
Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer.Clinical cancer research : an official journal of the American Association for Cancer Research, 5 2
A. Mittelman, Z. Chen, Hong Yang, G. Wong, S. Ferrone (1992)
Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.Proceedings of the National Academy of Sciences of the United States of America, 89 2
E. Shevach (2004)
Fatal attraction: tumors beckon regulatory T cellsNature Medicine, 10
T. Curiel (2007)
Tregs and rethinking cancer immunotherapy.The Journal of clinical investigation, 117 5
K. Knutson, Y. Dang, Hailing Lu, J. Lukas, B. Almand, E. Gad, E. Azeke, M. Disis (2006)
IL-2 Immunotoxin Therapy Modulates Tumor-Associated Regulatory T Cells and Leads to Lasting Immune-Mediated Rejection of Breast Cancers in neu-Transgenic Mice1The Journal of Immunology, 177
T. Whiteside (2006)
Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention.Seminars in cancer biology, 16 1
N. Bhowmick, H. Moses (2005)
Tumor-stroma interactions.Current opinion in genetics & development, 15 1
Peter Attia, A. Maker, Leah Haworth, Linda Rogers-Freezer, S. Rosenberg (2005)
Inability of a Fusion Protein of IL-2 and Diphtheria Toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to Eliminate Regulatory T Lymphocytes in Patients With MelanomaJournal of Immunotherapy, 28
S. Ostrand-Rosenberg (2004)
Animal models of tumor immunity, immunotherapy and cancer vaccines.Current opinion in immunology, 16 2
Alfred Chang, A. Aruga, M. Cameron, V. Sondak, D. Normolle, B. Fox, S. Shu (1997)
Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 15 2
R. Ferris, T. Whiteside, S. Ferrone (2006)
Immune Escape Associated with Functional Defects in Antigen-Processing Machinery in Head and Neck CancerClinical Cancer Research, 12
R. Talpur, Daniel Jones, A. Alencar, N. Apisarnthanarax, K. Herne, Ying Yang, M. Duvic (2006)
CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphoma.The Journal of investigative dermatology, 126 3
L. Llorente, Y. Richaud-Patin, C. García-Padilla, E. Claret, J. Jakez-Ocampo, M. Cardiel, J. Alcocer-Varela, L. Grangeot‐Keros, D. Alarcon-segovia, J. Wijdenes, P. Galanaud, D. Émilie (2000)
Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus.Arthritis and rheumatism, 43 8
P. Srivastava (2006)
Therapeutic cancer vaccines.Current opinion in immunology, 18 2
Maria Roncarolo, S. Gregori, M. Battaglia, R. Bacchetta, K. Fleischhauer, M. Levings (2006)
Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humansImmunological Reviews, 212
Guangyong Peng, Zhong Guo, Y. Kiniwa, K. Voo, W. Peng, T. Fu, D. Wang, Yanchun Li, Helen Wang, Rong-Fu Wang (2005)
Toll-Like Receptor 8-Mediated Reversal of CD4+ Regulatory T Cell FunctionScience, 309
E. Woo, H. Yeh, C. Chu, K. Schlienger, R. Carroll, J. Riley, L. Kaiser, C. June (2002)
Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell Proliferation1The Journal of Immunology, 168
U. Liyanage, P. Goedegebuure, T. Moore, C. Viehl, T. Moo-Young, J. Larson, D. Frey, J. Ehlers, T. Eberlein, D. Linehan (2006)
Increased Prevalence of Regulatory T Cells (Treg) is Induced by Pancreas AdenocarcinomaJournal of Immunotherapy, 29
M. Lutsiak, R. Semnani, R. Pascalis, S. Kashmiri, J. Schlom, H. Sabzevari (2005)
Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide.Blood, 105 7
R. Steinman, D. Hawiger, M. Nussenzweig (2003)
Tolerogenic dendritic cells.Annual review of immunology, 21
T. Reichert, L. Strauss, E. Wagner, W. Gooding, T. Whiteside (2002)
Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research, 8 10
T. Waldmann, J. Morris (2006)
Development of antibodies and chimeric molecules for cancer immunotherapy.Advances in immunology, 90
M. Terabe, S. Matsui, N. Noben-Trauth, Hangjiong Chen, C. Watson, D. Donaldson, D. Carbone, W. Paul, J. Berzofsky (2000)
NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathwayNature Immunology, 1
T. Boon, P. Coulie, B. Eynde, P. Bruggen (2006)
Human T cell responses against melanoma.Annual review of immunology, 24
F. Vianello, N. Papeta, Tao Chen, P. Kraft, N. White, W. Hart, M. Kircher, E. Swart, S. Rhee, G. Palù, D. Irimia, M. Toner, R. Weissleder, M. Poznansky (2006)
Murine B16 Melanomas Expressing High Levels of the Chemokine Stromal-Derived Factor-1/CXCL12 Induce Tumor-Specific T Cell Chemorepulsion and Escape from Immune Control1The Journal of Immunology, 176
F. Marincola, E. Jaffee, D. Hicklin, S. Ferrone (2000)
Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.Advances in immunology, 74
Jeong-Whun Kim, T. Tsukishiro, Jonas Johnson, T. Whiteside (2004)
Expression of Pro- and Antiapoptotic Proteins in Circulating CD8+ T Cells of Patients with Squamous Cell Carcinoma of the Head and NeckClinical Cancer Research, 10
Weihong Liu, A. Putnam, Xu-yu Zhou, G. Szot, Michael Lee, Shirley Zhu, P. Gottlieb, P. Kapranov, T. Gingeras, Barbara Groth, C. Clayberger, David Soper, S. Ziegler, J. Bluestone (2006)
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cellsThe Journal of Experimental Medicine, 203
L. Zitvogel, A. Tesnière, G. Kroemer (2006)
Cancer despite immunosurveillance: immunoselection and immunosubversionNature Reviews Immunology, 6
T. Whiteside (2002)
Tumor-induced death of immune cells: its mechanisms and consequences.Seminars in cancer biology, 12 1
H. Weiner (2001)
Induction and mechanism of action of transforming growth factor‐β‐secreting Th3 regulatory cellsImmunological Reviews, 182
P. Coulie, P. Bruggen (2003)
T-cell responses of vaccinated cancer patients.Current opinion in immunology, 15 2
R. Craig (2002)
MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesisLeukemia, 16
G. Rabinovich, D. Gabrilovich, E. Sotomayor (2007)
Immunosuppressive strategies that are mediated by tumor cells.Annual review of immunology, 25
T. Tsukishiro, A. Donnenberg, T. Whiteside (2003)
Rapid turnover of the CD8+CD28- T-cell subset of effector cells in the circulation of patients with head and neck cancerCancer Immunology, Immunotherapy, 52
N. Hiraoka, K. Onozato, T. Kosuge, S. Hirohashi (2006)
Prevalence of FOXP3+ Regulatory T Cells Increases During the Progression of Pancreatic Ductal Adenocarcinoma and Its Premalignant LesionsClinical Cancer Research, 12
N. Seddiki, B. Santner‐Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, Michael Solomon, W. Selby, S. Alexander, R. Nanan, A. Kelleher, Barbara Groth (2006)
Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cellsThe Journal of Experimental Medicine, 203
S. Sakaguchi, N. Sakaguchi, J. Shimizu, S. Yamazaki, T. Sakihama, M. Itoh, Y. Kuniyasu, T. Nomura, M. Toda, Takeshi Takahashi (2001)
Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation toleranceImmunological Reviews, 182
S. Miescher, T. Whiteside, S. Carrel, V. Fliedner (1986)
Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes.Journal of immunology, 136 5
A. Maker, Peter Attia, S. Rosenberg (2005)
Analysis of the Cellular Mechanism of Antitumor Responses and Autoimmunity in Patients Treated with CTLA-4 BlockadeThe Journal of Immunology, 175
Carsten Schaefer, GG Kim, A. Albers, K. Hoermann, EN Myers, T. Whiteside (2005)
Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancerBritish Journal of Cancer, 92
A. Hurwitz, Tina Yu, D. Leach, J. Allison (1998)
CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.Proceedings of the National Academy of Sciences of the United States of America, 95 17
Jun Wang, A. Ioan-Facsinay, Ellen I. H. van der Voort, T. Huizinga, R. Toes (2007)
Transient expression of FOXP3 in human activated nonregulatory CD4+ T cellsEuropean Journal of Immunology, 37
H. Jonuleit, E. Schmitt, M. Stassen, A. Tuettenberg, J. Knop, A. Enk (2001)
Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral BloodThe Journal of Experimental Medicine, 193
L. Strauss, C. Bergmann, W. Gooding, Jonas Johnson, T. Whiteside (2007)
The Frequency and Suppressor Function of CD4+CD25highFoxp3+ T Cells in the Circulation of Patients with Squamous Cell Carcinoma of the Head and NeckClinical Cancer Research, 13
S. Allan, S. Crome, N. Crellin, L. Passerini, T. Steiner, R. Bacchetta, M. Roncarolo, M. Levings (2007)
Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.International immunology, 19 4
B. Bisikirska, J. Colgan, J. Luban, J. Bluestone, K. Herold (2005)
TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs.The Journal of clinical investigation, 115 10
J. Galon, A. Costes, F. Sánchez-Cabo, A. Kirilovsky, B. Mlecnik, C. Lagorce-Pagès, M. Tosolini, M. Camus, A. Berger, P. Wind, F. Zinzindohoué, P. Bruneval, P. Cugnenc, Z. Trajanoski, W. Fridman, F. Pagès (2006)
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 313
Mary Litzinger, R. Fernando, T. Curiel, D. Grosenbach, J. Schlom, C. Palena (2007)
IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity.Blood, 110 9
I. Tourkova, G. Shurin, G. Chatta, L. Perez, J. Finke, T. Whiteside, S. Ferrone, M. Shurin (2005)
Restoration by IL-15 of MHC Class I Antigen-Processing Machinery in Human Dendritic Cells Inhibited by Tumor-Derived Gangliosides1The Journal of Immunology, 175
N. Rouas-Freiss, P. Moreau, S. Ferrone, E. Carosella (2005)
HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?Cancer research, 65 22
I. Kuss, Bridget Hathaway, R. Ferris, W. Gooding, T. Whiteside (2004)
Decreased Absolute Counts of T Lymphocyte Subsets and Their Relation to Disease in Squamous Cell Carcinoma of the Head and NeckClinical Cancer Research, 10
C. Galustian, Deborah Klaschka, B. Meyer, M. Labarthe, J. Bartlett, A. Dalgleish (2006)
Lenalidomide (Revlimid®, CC-5013) and Actimid™ (CC-4047) inhibit the function and expansion of T regulatory (Treg) cells in vitro: Implications for anti-tumor activity in vivoCancer Research, 66
T. Curiel, G. Coukos, L. Zou, Xavier Alvarez, P. Cheng, P. Mottram, Melina Evdemon-Hogan, J. Conejo-Garcia, Lin Zhang, M. Burow, Yun Zhu, Shuang Wei, Ilona Kryczek, B. Daniel, Alan Gordon, L. Myers, A. Lackner, M. Disis, K. Knutson, Lieping Chen, W. Zou (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalNature Medicine, 10
L. Strauss, C. Bergmann, M. Szczepański, W. Gooding, Jonas Johnson, T. Whiteside (2007)
A Unique Subset of CD4+CD25highFoxp3+ T Cells Secreting Interleukin-10 and Transforming Growth Factor-β1 Mediates Suppression in the Tumor MicroenvironmentClinical Cancer Research, 13
D. Fisher, Qing Chen, M. Appenheimer, J. Skitzki, Wan‐Chao Wang, K. Odunsi, S. Evans (2006)
Hurdles to Lymphocyte Trafficking in the Tumor Microenvironment: Implications for Effective ImmunotherapyImmunological Investigations, 35
W. Ng, Phillip Duggan, F. Ponchel, G. Matarese, G. Lombardi, A. Edwards, J. Isaacs, R. Lechler (2001)
Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.Blood, 98 9
D. Dieckmann, Heidi Plottner, S. Berchtold, T. Berger, G. Schuler (2001)
Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human BloodThe Journal of Experimental Medicine, 193
L. Strauss, C. Bergmann, T. Whiteside (2007)
Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancerInternational Journal of Cancer, 121
L. Strauss, T. Whiteside, A. Knights, C. Bergmann, A. Knuth, A. Zippelius (2007)
Selective Survival of Naturally Occurring Human CD4+CD25+Foxp3+ Regulatory T Cells Cultured with Rapamycin1The Journal of Immunology, 178
C.-C. Chang, R. Ciubotariu, J. Manavalan, J. Yuan, A. Colovai, F. Piazza, S. Lederman, M. Colonna, R. Cortesini, R. Dalla-Favera, N. Suciu-Foca (2002)
Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4Nature Immunology, 3
N. Larmonier, M. Marron, Yi Zeng, J. Cantrell, Angela Romanoski, M. Sepassi, S. Thompson, Xinchun Chen, S. Andreansky, Emmanuel Katsanis (2006)
Tumor-derived CD4+CD25+ regulatory T cell suppression of dendritic cell function involves TGF-β and IL-10Cancer Immunology, Immunotherapy, 56
K. Schluns, L. Lefrançois (2003)
Cytokine control of memory T-cell development and survivalNature Reviews Immunology, 3
G. Trinchieri (2003)
Interleukin-12 and the regulation of innate resistance and adaptive immunityNature Reviews Immunology, 3
H. Khong, N. Restifo (2002)
Natural selection of tumor variants in the generation of “tumor escape” phenotypesNature Immunology, 3
D. Speiser, P. Romero (2005)
Toward improved immunocompetence of adoptively transferred CD8+ T cells.The Journal of clinical investigation, 115 6
Chien-Chung Chang, M. Campoli, S. Ferrone (2005)
Classical and nonclassical HLA class I antigen and NK Cell-activating ligand changes in malignant cells: current challenges and future directions.Advances in cancer research, 93
M. Beyer, J. Schultze (2006)
Regulatory T cells in cancer.Blood, 108 3
G. Betts, S. Clarke, H. Richards, A. Godkin, A. Gallimore (2006)
Regulating the immune response to tumours.Advanced drug delivery reviews, 58 8
Chien-Chung Chang, S. Ferrone (2006)
Immune selective pressure and HLA class I antigen defects in malignant lesionsCancer Immunology, Immunotherapy, 56
C. Uyttenhove, L. Pilotte, I. Theate, V. Stroobant, D. Colau, Nicolas Parmentier, T. Boon, B. Eynde (2003)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenaseNature Medicine, 9
Surgical Oncology Clinics of North America – Pubmed
Published: Apr 3, 2008
Access the full text.
Sign up today, get DeepDyve free for 14 days.